Sanj K. Patel, Chairman & CEO at Kiniksa Pharmaceuticals, Ltd. (KNSA), sold 33,115 shares at $20.00 ($662K) on 2020-03-06, disclosed to the SEC on 2020-03-10.
Open-market sale of $662k KNSA by Chairman & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| KNSA | SELL | 2026-04-08 | $364K | — | Filing → |
| KNSA | SELL | 2025-10-22 | $20.0M | — | Filing → |
| KNSA | SELL | 2025-05-28 | $4.6M | — | Filing → |